Titan Pharmaceuticals, Inc.
Climate Impact & Sustainability Data (2022)
Reporting Period: 2022
Environmental Metrics
Climate Goals & Targets
Environmental Challenges
- Non-compliance with Nasdaq minimum bid price requirement ($1.00 per share for 30 days ending March 15, 2023).
- Non-compliance with Nasdaq stockholders' equity requirement (at least $2,500,000).
Mitigation Strategies
- Private placement of Series AA Convertible Preferred Stock raising $9,500,000.
- Sale of ProNeura assets on September 1, 2023.
- Intention to appeal Nasdaq's delisting determination.
- Intention to evaluate options to resolve deficiencies, including a reverse stock split.